Techno Drugs Ltd. (DSE:TECHNODRUG)
27.10
+1.20 (4.63%)
At close: May 8, 2025
Techno Drugs Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 408.89 | 321.08 | 34.47 | 139.94 |
Short-Term Investments | 31.37 | 47.34 | 53.22 | 30.6 |
Cash & Short-Term Investments | 440.26 | 368.42 | 87.69 | 170.53 |
Cash Growth | 158.16% | 320.15% | -48.58% | - |
Accounts Receivable | 1,211 | 958.96 | 789.71 | 707.18 |
Other Receivables | - | 41.04 | 41.04 | 41.04 |
Receivables | 1,211 | 1,000 | 830.76 | 748.22 |
Inventory | 948.48 | 856.87 | 939.14 | 646.64 |
Prepaid Expenses | - | 4.54 | 5.55 | 4.27 |
Other Current Assets | 681.45 | 397.74 | 352.6 | 299.12 |
Total Current Assets | 3,281 | 2,628 | 2,216 | 1,869 |
Property, Plant & Equipment | 3,954 | 3,869 | 3,818 | 3,492 |
Long-Term Investments | 0.27 | 0.27 | 0.27 | 0.27 |
Other Intangible Assets | 5.93 | 6.39 | 7.22 | 3.09 |
Total Assets | 7,241 | 6,503 | 6,041 | 5,364 |
Accounts Payable | 170.42 | 76.72 | 78.06 | 65.92 |
Accrued Expenses | 77.72 | 155.74 | 186.26 | 148.25 |
Short-Term Debt | 646.49 | 920.1 | 1,188 | 854.58 |
Current Portion of Long-Term Debt | 419.06 | 509.8 | 414.02 | 474.44 |
Current Portion of Leases | 31.06 | 40.78 | 27.76 | 21.27 |
Current Income Taxes Payable | 216.02 | 179.1 | 215.27 | 162.21 |
Current Unearned Revenue | - | 12.32 | 3.22 | - |
Other Current Liabilities | 59.07 | 16.29 | 11.49 | 7.54 |
Total Current Liabilities | 1,620 | 1,911 | 2,124 | 1,734 |
Long-Term Debt | 1,452 | 1,212 | 1,056 | 973.76 |
Long-Term Leases | 57.08 | 57.1 | 32.92 | 32.19 |
Long-Term Deferred Tax Liabilities | 163.75 | 168.41 | 216.49 | 191.45 |
Other Long-Term Liabilities | - | - | -0 | -0 |
Total Liabilities | 3,293 | 3,348 | 3,429 | 2,932 |
Common Stock | 1,320 | 941.57 | 941.57 | 941.57 |
Retained Earnings | 1,519 | 1,464 | 1,183 | 987.83 |
Comprehensive Income & Other | 487.44 | 748.98 | 487.44 | 502.99 |
Shareholders' Equity | 3,948 | 3,154 | 2,612 | 2,432 |
Total Liabilities & Equity | 7,241 | 6,503 | 6,041 | 5,364 |
Total Debt | 2,606 | 2,740 | 2,718 | 2,356 |
Net Cash (Debt) | -2,166 | -2,371 | -2,630 | -2,186 |
Net Cash Per Share | -18.98 | -24.85 | -27.94 | -23.21 |
Filing Date Shares Outstanding | 132 | 94.16 | 94.16 | 94.16 |
Total Common Shares Outstanding | 132 | 94.16 | 94.16 | 94.16 |
Working Capital | 1,661 | 716.73 | 91.79 | 134.58 |
Book Value Per Share | 29.91 | 33.50 | 27.74 | 25.83 |
Tangible Book Value | 3,942 | 3,148 | 2,605 | 2,429 |
Tangible Book Value Per Share | 29.87 | 33.43 | 27.67 | 25.80 |
Land | - | 770.52 | 770.52 | 769.57 |
Buildings | - | 2,154 | 1,877 | 1,686 |
Machinery | - | 2,468 | 2,353 | 2,050 |
Construction In Progress | - | 132.73 | 179.88 | 49.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.